A novel method to address the association between received dose intensity and survival outcome: benefits of approaching treatment intensification at a more individualised level in a trial of the European Osteosarcoma Intergroup. (2019)
Attributed to:
Analysis of trials, meta-analyses and observational studies
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s00280-019-03797-3
PubMed Identifier: 30879111
Publication URI: http://europepmc.org/abstract/MED/30879111
Type: Journal Article/Review
Volume: 83
Parent Publication: Cancer chemotherapy and pharmacology
Issue: 5
ISSN: 0344-5704